DRKS00019047已完成不适用
AURORA: Characterization of HIV-positive treatment-naïve patients under real-life conditions in Germany - Aurora 7519
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 355
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 Years 至 one（—）
- 性别
- All
入选标准
- •1) Confirmed infection with HIV-1 (positive HIV test according to appropriate standard practice [e.g. PCR test])
- •2) Antiretroviral therapeutic-naïve before the baseline visit
- •3) Decision on antiretroviral therapy was made before inclusion in the study and prescribed at the baseline visit
- •4) Baseline visit is a current visit or was not more than 2 years before study start
- •5) Written informed consent given
排除标准
- •1) Existent contraindication/intolerability against the selected antiretroviral therapy or its components
- •2) Patients who started their ART before market authorization of the used compound(s) in Germany, e.g. participants of clinical trial(s)
- •3) Investigator considers patient's available information (especially on concomitant diseases and co-medications) as unreliable or incomplete
研究者
相似试验
已完成
不适用
Highly Active Antiretroviral Treatment (HAART) of Human Immunodeficiency Virus (HIV)-infection in a town in Cameroon: randomised controlled study to suggest which treatment starting point is most beneficial for the patientsHIV infectionInfections and InfestationsHIVISRCTN22114173Institute of Community Medicine, University of Tromsø (Norway)100
已完成
不适用
Directly Observed antiretroviral Therapy for people living with Human Immunodeficiency Virus (HIV) and Acquired ImmunDeficiency Syndrome (AIDS): a randomised controlled trialISRCTN48682427Ministry of Health (Brazil)
已完成
不适用
Highly active anti-retroviral therapy including nevirapine once daily versus twice daily after at least 12 weeks of nevirapine twice daily. A randomized, open, multicentre trial.ISRCTN81305260Institute of Biomedical Investigations of Bellvitge (Institut d'Investigació Biomèdica de Bellvitge) (IDIBELL) (Spain)308
招募中
不适用
Clinical investigation of HIV infection diagnostic kitHIV infectionJPRN-UMIN000021201Keio University School of Medicine Center for Infectious Disease and Infection Control200
进行中（未招募）
1 期
Short pulse antiretroviral therapy at HIV seroconversion:A multi-centre randomised trial of therapeutic intervention at primary HIV-1 infection. Tratamiento antirretroviral en pulsos cortos en la seroconversión por el VIH: ensayo clínico aleatorizado, multicéntrico, de intervención terapéutica en la infección primaria por VIH-1. - SPARTACprimary HIV infection infección primaria por el VIHMedDRA version: 9.1 Level: LLT Classification code 10058427 Term: Primary HIV infectionEUCTR2004-000446-20-ESImperial College371